Comparing costs of intramuscular and oral vitamin B12 administration in primary care: A cost-minimization analysis

European Journal of General Practice

Volumn 12, Issue 4, 2006, Pages 169-173

  Vidal Alaball, Josep ^a   Butler, Christopher C ^b   Potter, Christopher C ^a  

^a PUBLIC HEALTH WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cobalamin; Cost minimization; Pernicious anaemia; Vitamin B12

Indexed keywords

CYANOCOBALAMIN;

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST MINIMIZATION ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG MEGADOSE; HEALTH CARE COST; HUMAN; MEDICAL LITERATURE; NURSING CARE; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; TREATMENT OUTCOME; UNITED KINGDOM; WELLBEING; COMPARATIVE STUDY; ECONOMICS; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIMARY HEALTH CARE;

ADMINISTRATION, ORAL; COST-BENEFIT ANALYSIS; HUMANS; INJECTIONS, INTRAMUSCULAR; PRIMARY HEALTH CARE; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 34547416000     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430601049449     Document Type: Article

References (19)

1. 12. Science, 107, p. 396.
2. Smith, E. (1948) Purification of anti-pernicious anaemia factor from liver. Nature, 161, p. 638.
3. Rajan, S., Wallace, JI, Beresford, SA, Brodkin, KI, Allen, RA and Stabler, SP (2002) Screening for cobalamin deficiency in geriatric outpatients: Prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc, 50, pp. 624-630.
4. 12 and folate deficiency in later life. Age Ageing, 33, pp. 34-41.
5. 12 by mouth in pernicious and nutritional macrocytic anaemia and sprue. Lancet, 2, pp. 454-456.
6. 12 in pernicious anaemia. I. Oral administration without source of intrinsic factor. Br Med J, 2, pp. 905-908.
7. 12 without intrinsic factor. New Engl J Med, 12, pp. 502-506.
8. Unglaub, WG and Goldsmith, G. (1955) Oral vitamin B12 in the treatment of macrocytic anemias. South Med J, 48, pp. 261-269.
9. McIntyre, PAHR, Masters, JM and Krevans, JR. (1960) Treatment of pernicious anemia with orally administered cyanocobalamin (vitamin B12). Arch Intern Med, 106, pp. 280-292.
10. 12 without intrinsic factor. Acta Med Scand, 184, pp. 247-258.
11. 12 injections: considerable source of work for the district nurse. Br Med J (Clin Res Ed), 290, pp. 1254-1255.
12. Lederle, FA (1991) Oral cobalamin for pernicious anemia. Medicine's best kept secret?. JAMA, 265, pp. 94-95.
13. 12 in England and Wales. Br J Prev Soc Med, 25, pp. 147-151.
14. van Walraven, C., Austin, P. and Naylor, CD (2001) Vitamin B12 injections versus oral supplements. How much money could be saved by switching from injections to pills?. Can Fam Physician, 47, pp. 79-86.
15. 12 deficiency (Review). The Cochrane Library, 2005
16. British Medical Association and Royal Pharmaceutical Society of Great Britain.51, p. 467.
17. Hughes, D. (1991) Costing consultations in general practice: Towards a standardized method. Fam Pract, 8, pp. 388-393.
18. Norberg, B. Oral high-dose cyanocobalamin-a contagious concept.
19. 12: oral compared with parenteral?. Postgrad Med J, 81, pp. 191-193.